Baxter (BAX) ebitda was $952M in FY2025 (-25% YoY). The tables below show the complete quarterly and annual ebitda history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual EBITDA
Fiscal Year
EBITDA
YoY
2025
$952M
-25%
2024
$1.3B
-35%
2023
$1.9B
+231%
2022
-$1.5B
-161%
2021
$2.5B
-8%
2020
$2.7B
-5%
2019
$2.8B
+9%
2018
$2.6B
+17%
2017
$2.2B
+14%
2016
$1.9B
+33%
2015
$1.5B
-1%
2014
$1.5B
+5%
2013
$1.4B
-61%
2012
$3.6B
-4%
2011
$3.7B
+27%
2010
$2.9B
-20%
2009
$3.7B
+9%
2008
$3.3B
+13%
2007
$3.0B
Recent Quarterly EBITDA
Quarter
EBITDA
Q2 2026
$346M
Q1 2026
$374M
Q4 2025
-$87M
Q3 2025
$334M
Q2 2025
$346M
Q1 2025
$359M
Q4 2024
$272M
Q3 2024
$303M
Q2 2024
$276M
Q1 2024
$420M
Q4 2023
$706M
Q3 2023
$395M
Source: BAX on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.